Aligos Therapeutics Inc (ALGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
Sales | 2,723 | 3,537 | 4,106 | 3,693 | 2,571 |
Gross Profit | 2,723 | 3,537 | 4,106 | 3,693 | 2,571 |
Operating Expenses | 26,641 | 26,219 | 23,054 | 24,086 | 38,128 |
Operating Income | -23,918 | -22,682 | -18,948 | -20,393 | -35,557 |
Other Income | 1,002 | 845 | 284 | 516 | -5 |
Pre-tax Income | -22,916 | -21,837 | -18,664 | -19,877 | -35,562 |
Income Tax | 39 | 49 | -43 | 47 | 53 |
Net Income Continuous | -22,955 | -21,886 | -18,621 | -19,924 | -35,615 |
Net Income | $-22,955 | $-21,886 | $-18,621 | $-19,924 | $-35,615 |
EPS Basic Total Ops | -13.25 | -12.50 | -11.00 | -11.75 | -21.00 |
EPS Basic Continuous Ops | -13.37 | -12.73 | -10.89 | -11.67 | -20.94 |
EPS Diluted Total Ops | -13.25 | -12.50 | -11.00 | -11.75 | -21.00 |
EPS Diluted Continuous Ops | -13.37 | -12.73 | -10.89 | -11.67 | -20.94 |
EPS Diluted Before Non-Recurring Items | -13.25 | -12.75 | -11.00 | N/A | N/A |
EBITDA(a) | $-23,341 | $-21,860 | $-18,111 | $-19,528 | $-34,565 |